CDMO.Avid Bioservices, INC

Form 4: Avid Bioservices Director Richard B. Hancock Reports Stock Transactions

Sentiment:

SEC Form 4

📋All filings for Avid Bioservices, INC
🔒Login to Follow

Richard B. Hancock, a director at Avid Bioservices, Inc., reported the vesting of restricted stock units and a new equity award grant.

Summary

  • Director Richard B. Hancock reported transactions involving Avid Bioservices, Inc. stock.
  • On December 14, 2024, 26,756 restricted stock units (RSUs) vested, converting into 26,756 shares of common stock.
  • These RSUs were granted on December 14, 2023, and vested as part of the non-employee director compensation program.
  • Additionally, on December 14, 2024, Hancock received an annual equity award grant of 8,147 RSUs.
  • These new RSUs will vest on December 14, 2025, contingent on continuous service as a director.

Sentiment

Score: 7

Explanation: The document reflects standard director compensation practices, indicating a neutral to slightly positive sentiment due to the alignment of director interests with the company's performance.

Positives

  • The vesting of RSUs indicates the fulfillment of previous compensation agreements.
  • The new equity award grant aligns the director's interests with the company's long-term performance.

Future Outlook

The newly granted RSUs will vest on December 14, 2025, contingent on the director's continued service.

Industry Context

This is a standard SEC Form 4 filing related to director compensation, which is common practice for publicly traded companies.

Comparison to Industry Standards

  • Equity compensation for directors is a common practice in publicly traded companies like Avid Bioservices.
  • The vesting schedule of one year for the initial grant and the new grant is typical for director equity awards.
  • Companies such as Catalent, Lonza, and Samsung Biologics also use similar equity-based compensation for their directors.

Stakeholder Impact

  • The vesting of RSUs and new grants may have a minor positive impact on shareholder confidence due to the alignment of director interests with the company's performance.

Key Dates

DateDescription
12/14/2023Date of the grant of the restricted stock units that vested on December 14, 2024.
12/14/2024Date of vesting of 26,756 restricted stock units and grant of 8,147 new restricted stock units.
12/14/2025Vesting date for the 8,147 restricted stock units granted on December 14, 2024.
12/17/2024Date the SEC Form 4 was signed.

Keywords

Avid Bioservices, Director, Richard B. Hancock, Restricted Stock Units, RSU, Stock Vesting, Equity Award, Director Compensation, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.